Company: IXHL
Filing Date: 2025-03-18
Form Type: PRE 14A
Source: 0001213900-25-024754
Chunk: 25

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-18
Form: PRE 14A
Chunk 25
---
URTHER, THAT IF A STOCKHOLDER HAS SHARES OF COMMON STOCK THAT ARE SUBJECT TO THE VOTING RESTRICTION AND ARE NOT ENTITLED TO VOTE ON THIS PROPOSAL 1 AND SUCH STOCKHOLDER DOES NOT SPECIFY ON ITS PROXY CARD OR VOTING INSTRUCTION FORM HOW SUCH STOCKHOLDER’S SHARES ARE TO BE VOTED ON THIS PROPOSAL NO. 1, ANY SHARES THAT ARE NOT SUBJECT TO THE VOTING RESTRICTION AND ARE ENTITLED TO VOTE ON PROPOSAL NO 1 WILL BE VOTED IN FAVOR OF THIS PROPOSAL NO 1, AND ANY SHARES THAT ARE SUBJECT TO THE VOTING RESTRICTION AND ARE NOT ENTITLED TO VOTE ON PROPOSAL NO. 1 WILL NOT BE VOTED ON THIS PROPOSAL NO. 1.

<div align='center'>14

Proposal No. 2
APPROVAL OF THE CHARTER AMENDMENT PROPOSAL</div>

Our board of directors has
determined that it is advisable to increase the number of shares of our common stock authorized for issuance under our Amended and Restated
Certificate of Incorporation from 100,000,000 shares to 800,000,000 shares, and has voted to recommend that the stockholders adopt an
amendment to our Amended and Restated Certificate of Incorporation effecting the proposed increase. The full text of the Certificate of
Amendment to the Amended and Restated Certificate of Incorporation is attached to this proxy statement as . If our stockholders
approve the proposal, subject to the discretion of the board of directors, we will file the Certificate of Amendment to our Amended and
Restated Certificate of Incorporation with the Secretary of State of the State of Delaware as soon as practicable.

As of March 12, 2025, 27,546,753
shares of our common stock were issued and outstanding, an additional approximately 6,481,440 shares were reserved for issuance under
our various stock-based plans and awards granted thereunder or upon the exercise of outstanding warrants (other than the Warrants issued
in the Private Placement) and the remaining approximately 65,971,807 of our authorized shares were reserved for issuance upon the exercise
of the Warrants issued in the Private Placement. Accordingly, no shares of common stock are available for future purposes or issuances.
As of the closing of the Private Placement on March 10, 2025, we